4.8 Article

Mutational Processes Molding the Genomes of 21 Breast Cancers

Journal

CELL
Volume 149, Issue 5, Pages 979-993

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2012.04.024

Keywords

-

Funding

  1. Wellcome Trust [098051]
  2. Breakthrough Breast Cancer Research [ICGC 08/09]
  3. Wellcome Trust Clinical Research
  4. Wellcome Trust Senior Clinical Research [WT088340MA]
  5. Research Foundation - Flanders [FWO]
  6. National Research Council Canada
  7. EMBO
  8. International Human Frontier Science Program Organization
  9. Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research
  10. Norwegian Research Council
  11. The Norwegian Cancer Society
  12. The Radium Hospital Foundation
  13. Health Region South-East
  14. European Community [242006]
  15. Breast Cancer Somatic Genetics Study [BASIS]
  16. Wellcome Trust Sanger Institute
  17. Breakthrough Breast Cancer Unit
  18. ICGC Breast Cancer Working Group
  19. Oslo University Hospital
  20. United States National Cancer Institute Specialized Program Of Research Excellence [CA089393]
  21. Centre for Translational Genomics (CTAG)
  22. Department of Health via NIHR comprehensive Biomedical Research Centre
  23. NHS Foundation Trust, King's College London
  24. King's College Hospital NHS Foundation Trust
  25. BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI
  26. MRC [MC_U105178806] Funding Source: UKRI
  27. Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish
  28. Medical Research Council [MC_U105178806] Funding Source: researchfish

Ask authors/readers for more resources

All cancers carry somatic mutations. The patterns of mutation in cancer genomes reflect the DNA damage and repair processes to which cancer cells and their precursors have been exposed. To explore these mechanisms further, we generated catalogs of somatic mutation from 21 breast cancers and applied mathematical methods to extract mutational signatures of the underlying processes. Multiple distinct single- and double-nucleotide substitution signatures were discernible. Cancers with BRCA1 or BRCA2 mutations exhibited a characteristic combination of substitution mutation signatures and a distinctive profile of deletions. Complex relationships between somatic mutation prevalence and transcription were detected. A remarkable phenomenon of localized hypermutation, termed kataegis,'' was observed. Regions of kataegis differed between cancers but usually colocalized with somatic rearrangements. Base substitutions in these regions were almost exclusively of cytosine at TpC dinucleotides. The mechanisms underlying most of these mutational signatures are unknown. However, a role for the APOBEC family of cytidine deaminases is proposed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available